Physician profile
Elmo M Agatep
NPI 1043228224
$406.41
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2021: $27.56 · 2022: $66.16 · 2023: $19.52 · 2024: $45.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $114.28 | 2019-2023 | Shingrix, Bexsero |
| Abbvie INC. | $51.95 | 2019 | |
| Gilead Sciences, INC. | $48.86 | 2019-2024 | |
| Pfizer INC. | $36.98 | 2019 | |
| Novo Nordisk INC | $35.93 | 2019 | |
| Merck Sharp & Dohme LLC | $32.83 | 2019 | |
| Sanofi Pasteur INC. | $16.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.21 | 2024 | Airsupra |
| Adlon Therapeutics L.P. | $15.19 | 2021 | |
| Astellas Pharma US INC | $13.78 | 2019 | |
| Cranial Technologies, INC | $12.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elmo Agatep listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.